Compare PayPal Holdings, Inc. (PYPL) vs 10X Genomics Inc (TXG) Price & Performance

PayPal (PYPL) trades at $53.18, down 3.24% on the day, reflecting recent volatility amid takeover speculation collapse and restructuring efforts. The stock shows bearish technical signals with key support at $51, while fundamentals remain solid with a P/E of 10.05, net income margin of 14.36%, and consistent revenue growth to $33.17B in 2025. Recent news highlights a strategic shift under new CEO Enrique Lores, targeting $1.5B in savings and expanding beyond branded checkout.

The outlook is mixed; valuation appears attractive with a consensus price target of $59.61, but near-term risks include execution of the turnaround plan and competitive pressures. Investor sentiment is cautious with 60% analyst hold ratings, though strong cash flow and dividend initiation provide stability. Upside depends on successful cost savings and new growth initiatives offsetting market skepticism.

TXG trades at $65.60, up 4.71% today, with strong technical momentum showing bullish moving averages and key support at $63. Fundamentally, the company demonstrates improving trends with Q2 2026 earnings beating estimates and revenue growth guidance raised, though profitability remains negative with a -12.18% net margin. Recent patent victory against Parse Biosciences strengthens competitive positioning.

The outlook remains cautiously optimistic with analyst consensus at 45% buy ratings and $50.78 price target. Key opportunities include Atera platform adoption and consumables growth, while risks center on valuation premiums and ongoing profitability challenges. The stock trades near resistance at $67 with institutional interest showing mixed signals.